Drug intelligence / Profile preview

Compound Maodongqing

Development stage
Unknown
Lead developer
Shangqiu Zhongsen Pharmaceutical Technology
Modality
Small Molecules
Administration
Oral
01

Overview

Compound Maodongqing is a combination medication used in Traditional Chinese Medicine (TCM) for the treatment of the common cold, influenza, and associated symptoms such as fever, headache, and sore throat. The formulation typically integrates herbal extracts with Western pharmacological agents to provide a multi-targeted therapeutic effect. The primary herbal component is derived from *Ilex pubescens* (Maodongqing), which is traditionally valued for its heat-clearing, detoxifying, and anti-inflammatory properties. To enhance its efficacy against acute cold symptoms, the compound often includes paracetamol (acetaminophen) for its antipyretic and analgesic actions, and chlorpheniramine maleate, an antihistamine that relieves nasal congestion, sneezing, and rhinorrhea. Some formulations may also incorporate *Evodia lepta* (Sanchaku) for additional anti-inflammatory and analgesic support. It is commonly developed and manufactured by regional pharmaceutical companies in China, such as Shangqiu Zhongsen Pharmaceutical Technology, for over-the-counter use.

Brand names
Fufang Maodongqing
Other names
Compound Ilex PubescensFufang Maodongqing Pian
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Compound Maodongqing.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Compound Maodongqing.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call